ENTRY       D03959                      Drug
NAME        Efalizumab (USAN/INN);
            Raptiva (TN)
REMARK      ATC code: L04AA21
EFFICACY    Antipsoriatic, Immunosuppressant, Anti-CD11a antibody
  TYPE      Monoclonal antibody
COMMENT     Treatment of transplant rejections
TARGET      ITGAL (CD11A) [HSA:3683] [KO:K05718]
  PATHWAY   hsa04514(3683)  Cell adhesion molecules
            hsa04650(3683)  Natural killer cell mediated cytotoxicity
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
              L04 IMMUNOSUPPRESSANTS
               L04A IMMUNOSUPPRESSANTS
                L04AA Selective immunosuppressants
                 L04AA21 Efalizumab
                  D03959  Efalizumab (USAN/INN)
            Target-based classification of drugs [BR:br08310]
             Cell surface molecules and ligands
              Cell adhesion molecules: other families
               Integrins
                ITGAL (CD11A)
                 D03959  Efalizumab (USAN/INN)
DBLINKS     CAS: 214745-43-4
            PubChem: 47205946
///
